Steven Daniel Schwartz serves as Executive at Avalanche Biotechnologies, Inc., where they oversee executive responsibilities. Since joining the company, Steven Daniel Schwartz has executed 15 insider transactions totaling $8.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 12, 2017 involved receiving (via award) 22,727 shares valued at $0.
Steven Daniel Schwartz currently holds 398,991 shares of Avalanche Biotechnologies, Inc. (AAVL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven Daniel Schwartz has been a net seller of AAVL stock. They have purchased $0 and sold $8.9M worth of shares.
Steven Daniel Schwartz's most recent insider trade was on Jun 12, 2017, when they sold 22,727 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 15, 2015 | [AAVL] | $672.6K | Sale | 16,875 | $39.86 | Discretionary |
| Jun 1, 2015 | [AAVL] | $511.2K | Sale | 14,157 | $36.11 | Discretionary |
| Jun 1, 2015 | [AAVL] | $113.9K | Sale | 3,093 | $36.81 | Discretionary |
| May 22, 2015 | AAVL | $202.0K | Sale | 5,196 | $38.88 | Discretionary |
| May 22, 2015 | AAVL | $445.7K | Sale | 11,679 | $38.16 | Discretionary |
| May 8, 2015 | AAVL | $570.1K | Sale | 17,250 | $33.05 | Discretionary |
| Apr 23, 2015 | AAVL | $651.7K | Sale | 16,875 | $38.62 | Discretionary |
| Apr 21, 2015 | AAVL | $0 | Award | 2,000 | $N/A | Discretionary |
| Apr 9, 2015 | AAVL | $677.2K | Sale | 17,050 | $39.72 | Discretionary |
| Apr 9, 2015 | AAVL | $8.1K | Sale | 200 | $40.38 | Discretionary |
| Jan 13, 2015 | AAVL | $5.0M | Sale | 91,000 | $55.46 | Discretionary |
| Aug 5, 2014 | AAVL | $5.1K | Exercise | 34,000 | $0.15 | Discretionary |
| Aug 5, 2014 | AAVL | $0 | Conversion | 25,306 | $N/A | Discretionary |